Huskey S W, Doss G A, Miller R R, Schoen W R, Chiu S H
Department of Drug Metabolism, Merck Research Laboratories, Rahway, NJ 07065.
Drug Metab Dispos. 1994 Jul-Aug;22(4):651-8.
The relative intrinsic in vitro N-glucuronidation reactivity of three classes of heterocyclic compounds was compared using model compounds incubated with UDP-glucuronic acid-enriched liver microsomes from rats, monkeys, and humans. These compounds, all methylbiphenyl (MB) derivatives, represent three classes of N-containing heterocycles commonly used in the design of new drug entities [i.e MB-tetrazole, MB-triazole, (1,2,3- and 1,2,4-), and MB-imidazole (C2- and C4-substituted)]. The structures of all respective N-glucuronides generated from microsomal incubations were determined by Nuclear Overhauser Effect difference NMR spectroscopy. The chemical and enzymic stabilities of N-glucuronides were also studied. In general, relatively low reactivity was found at nitrogens located next to substituted carbons in heterocycles such as N3 in MB-C4-imidazole, N3 in MB-1,2,3-triazole, N2 (or N4) in MB-1,2,4-triazole, and N1 (or N4) in MB-tetrazole. MB-C2-imidazole, in which both nitrogens are in immediate neighboring positions of the substituted carbon, was unreactive toward N-glucuronidation. When the rate of N-glucuronidation was compared under optimal reaction conditions for each compound, most compounds showed higher reactivity with liver microsomes from monkeys than those from rats, except for N2-glucuronidation of MB-tetrazole and MB-1,2,3-triazole. However, the trend for the relative N-glucuronidation reactivity of these compounds by liver microsomes from humans is quite different from those by monkeys and rats.(ABSTRACT TRUNCATED AT 250 WORDS)
使用与来自大鼠、猴子和人类的富含尿苷二磷酸葡萄糖醛酸的肝微粒体一起孵育的模型化合物,比较了三类杂环化合物相对固有的体外N-葡萄糖醛酸化反应性。这些化合物均为甲基联苯(MB)衍生物,代表了常用于新药实体设计的三类含氮杂环 [即MB-四氮唑、MB-三氮唑(1,2,3-和1,2,4-)以及MB-咪唑(C2-和C4-取代)]。通过核Overhauser效应差核磁共振光谱法确定了微粒体孵育产生的所有相应N-葡萄糖醛酸苷的结构。还研究了N-葡萄糖醛酸苷的化学和酶稳定性。一般来说,在杂环中与取代碳相邻的氮处发现相对较低的反应性,例如MB-C4-咪唑中的N3、MB-1,2,3-三氮唑中的N3、MB-1,2,4-三氮唑中的N2(或N4)以及MB-四氮唑中的N1(或N4)。MB-C2-咪唑的两个氮都处于取代碳的紧邻位置,对N-葡萄糖醛酸化无反应。当在每种化合物的最佳反应条件下比较N-葡萄糖醛酸化速率时,除了MB-四氮唑和MB-1,2,3-三氮唑的N2-葡萄糖醛酸化外,大多数化合物与猴子肝微粒体的反应性高于与大鼠肝微粒体的反应性。然而,人类肝微粒体对这些化合物的相对N-葡萄糖醛酸化反应性趋势与猴子和大鼠的趋势有很大不同。(摘要截断于250字)